Study Reveals Coordinated DNA Methylation Patterns Across Cancer Types
Researchers analyzing DNA methylation (DNAm) in acute myeloid leukemia (AML) found that despite highly variable, patient-specific patterns, epigenetic changes are co-regulated in reproducible clusters across the genome. These coordinated networks were also observed in other leukemia types and across 46 additional cancer types, but not in non-malignant cells. The findings suggest cancer epigenetic dysregulation operates through a higher-order regulatory layer, potentially opening new avenues for understanding and targeting cancer-wide epigenetic disruption.
A new preprint study on bioRxiv examined DNA methylation patterns in acute myeloid leukemia (AML) and found that what appears to be highly heterogeneous, patient-specific epigenetic dysregulation is in fact organized into co-regulated clusters of CpG sites forming reproducible epigenetic networks. Multilinear regression models built from these networks accurately predicted patient-specific DNAm deviations, even across CpGs on different chromosomes, and the alterations were mirrored symmetrically on homologous chromosomes. Notably, these co-regulation patterns showed no clear association with known epigenetic driver mutations, suggesting the coordination arises from broader regulatory architecture rather than specific mutational events. Models derived from AML data successfully predicted DNAm changes in acute lymphoblastic leukemia (ALL), and the top 1,000 AML-associated CpGs showed pronounced aberrations across 46 other cancer types. Similar co-regulation networks were identified in non-malignant blood cells, though DNAm levels remained stable in those controls, implying the networks exist normally but become dysregulated in malignancy. The authors conclude that cancer-associated epigenetic landscapes are not random but are orchestrated within pre-existing higher-order regulatory frameworks.
What's missing
The study does not fully explain the mechanistic basis for how these epigenetic networks are coordinated or what upstream factors drive their dysregulation in cancer. It is also unclear whether the co-regulation patterns have direct functional consequences for gene expression or cancer progression, or whether they could serve as clinically actionable biomarkers.
What different sources said
- bioRxivCenter
Aberrant DNA methylation is co-regulated across the genome in leukemia and other types of cancer
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.